Pharvaris N.V. (PHVS)
NASDAQ: PHVS · IEX Real-Time Price · USD
16.85
-1.84 (-9.84%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $906.81 million as of July 2, 2024. Its market cap has increased by 80.86% in one year.
Market Cap
906.81M
Enterprise Value
511.09M
1-Year Change
80.86%
Ranking
Category
Stock Price
$16.85
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $906.81M, an increase of 42.40%. That is a compound annual growth rate of 10.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 906.80M | -21.12% |
| Dec 29, 2023 | 1.15B | 202.45% |
| Dec 30, 2022 | 380.10M | -20.26% |
| Dec 31, 2021 | 476.70M | -25.14% |
| Feb 5, 2021 | 636.80M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Owens & Minor | 1.03B |
| Tarsus Pharmaceuticals | 1.03B |
| Innoviva | 1.02B |
| MiMedx Group | 1.02B |
| Gyre Therapeutics | 1.02B |
| Cullinan Oncology | 1.01B |
| BioLife Solutions | 987.25M |
| Simulations Plus | 971.67M |